LABOCANNA S.A. ZY-10 Cash Flow Conversion Efficiency
LABOCANNA S.A. ZY-10 cash flow conversion efficiency. Based on the latest financial reports, LABOCANNA S.A. ZY-10 (9Y2) has a cash flow conversion efficiency ratio of -0.139x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-394.25K ≈ $-460.92K USD) by net assets (€2.83 Million ≈ $3.31 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of LABOCANNA S.A. ZY-10 (2022–2025)
Cash flow conversion efficiency of LABOCANNA S.A. ZY-10 from 2022 to 2025. This chart illustrates how LABOCANNA S.A. ZY-10's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 9Y2 share price today for real-time trading data and today's change.
LABOCANNA S.A. ZY-10 Cash Flow Conversion Ratio Explained
LABOCANNA S.A. ZY-10 cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
LABOCANNA S.A. ZY-10 Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of LABOCANNA S.A. ZY-10 ranked by their cash flow conversion efficiency. Also see how much is LABOCANNA S.A. ZY-10 worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Tessin Nordic Holding AB
ST:TESSIN
|
0.101x |
|
Veganz Group AG
F:VEZ
|
-0.582x |
|
Hotel Fast SSE AB (publ)
ST:MAXENT-B
|
0.004x |
|
Deutsche Effecten- und Wechsel-Beteiligungsgesellschaft AG
XETRA:EFF
|
0.000x |
|
Shree Ram Proteins Limited
NSE:SRPL
|
0.086x |
|
Europejskie Centrum Odszkodowań SA
WAR:EUC
|
0.002x |
|
Eco Animal Health Group Plc
LSE:EAH
|
-0.011x |
|
Maven Income And Growth Vct 3 Plc
LSE:MIG3
|
-0.009x |
Annual Cash Flow Conversion Efficiency for LABOCANNA S.A. ZY-10 (2022–2025)
The table below shows the annual cash flow conversion efficiency of LABOCANNA S.A. ZY-10 from 2022 to 2025. Review 9Y2 free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €5.72 Million ≈ $6.69 Million |
€-970.80K ≈ $-1.13 Million |
-0.170x | -24.13% |
| 2024-12-31 | €6.59 Million ≈ $7.70 Million |
€-901.00K ≈ $-1.05 Million |
-0.137x | +11.45% |
| 2023-12-31 | €7.01 Million ≈ $8.19 Million |
€-1.08 Million ≈ $-1.27 Million |
-0.154x | -310.60% |
| 2022-12-31 | €7.61 Million ≈ $8.89 Million |
€-286.11K ≈ $-334.49K |
-0.038x | -- |
About LABOCANNA S.A. ZY-10
Labocanna S.A. engages in the cultivation, production, and distribution of hemp product. The company also offers food and medical hemp-derived products, as well as CBD oil under the Labocanna brand name. It is also involved in commercial real estate management activities. Its products are used in cosmetics, plastics, and textiles. The company was formerly known as Foxbuy.com S.A. and changed its … Read more